10.3.2 Rubefacients


(including topical products containing nicotinate compounds, salicylate compounds, essential oils and camphor)

Following national guidance from NHS England, rubefacients are not recommended for use due to lack of evidence of efficacy. Click here for more information. Prescribers should not initiate rubefacients for any new patient. Click the following link for a patient information leaflet to support deprescribing


Home > Formulary > Chapters > 10. Musculoskeletal & joint diseases > 10.3 Drugs for the treatment of soft-tissue disorders and topical pain relief > 10.3.2 Rubefacients


  • First line
  • Second line
  • Specialist
  • Hospital